发布求助
文献互助 智能选刊 最新文献

Progress in medicinal chemistry最新文献

筛选
英文 中文
Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain. 小分子缓激肽B1受体拮抗剂作为潜在的疼痛治疗剂。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00004-5
Jian Jeffrey Chen, Kaustav Biswas
{"title":"Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain.","authors":"Jian Jeffrey Chen, Kaustav Biswas","doi":"10.1016/S0079-6468(07)00004-5","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00004-5","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"173-204"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00004-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. 11 -羟基类固醇脱氢酶1型抑制剂。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00002-1
Xiangdong Su, Nigel Vicker, Barry V L Potter
{"title":"Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.","authors":"Xiangdong Su, Nigel Vicker, Barry V L Potter","doi":"10.1016/S0079-6468(07)00002-1","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00002-1","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"29-130"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00002-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface. 适当选择生化靶点是新药发现过程中最重要的成本效益驱动因素之一。前言。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00008-2
G Lawton, D R Witty
{"title":"Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface.","authors":"G Lawton, D R Witty","doi":"10.1016/S0079-6468(07)00008-2","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00008-2","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"v-vi"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00008-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The discovery of raltegravir, an integrase inhibitor for the treatment of HIV infection. 发现用于治疗HIV感染的整合酶抑制剂雷替格拉韦。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00001-X
Michael Rowley
{"title":"The discovery of raltegravir, an integrase inhibitor for the treatment of HIV infection.","authors":"Michael Rowley","doi":"10.1016/S0079-6468(07)00001-X","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00001-X","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"1-28"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00001-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 50
Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market. 组蛋白去乙酰化酶抑制剂:一类即将上市的新型抗癌药物。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00005-7
Matthias Körner, Ulrich Tibes
{"title":"Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market.","authors":"Matthias Körner, Ulrich Tibes","doi":"10.1016/S0079-6468(07)00005-7","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00005-7","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"205-80"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00005-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
5-HT2C ligands: recent progress. 5-HT2C配体:最新进展。
Progress in medicinal chemistry Pub Date : 2008-01-01 DOI: 10.1016/S0079-6468(07)00006-9
Nathaniel J T Monck, Guy A Kennett
{"title":"5-HT2C ligands: recent progress.","authors":"Nathaniel J T Monck, Guy A Kennett","doi":"10.1016/S0079-6468(07)00006-9","DOIUrl":"https://doi.org/10.1016/S0079-6468(07)00006-9","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"46 ","pages":"281-390"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(07)00006-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27355616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Hit and Lead identification: efficient practices for drug discovery. Hit和Lead鉴定:药物发现的有效实践。
Progress in medicinal chemistry Pub Date : 2007-01-01 DOI: 10.1016/S0079-6468(06)45501-6
Robert A Goodnow, Paul Gillespie
{"title":"Hit and Lead identification: efficient practices for drug discovery.","authors":"Robert A Goodnow, Paul Gillespie","doi":"10.1016/S0079-6468(06)45501-6","DOIUrl":"https://doi.org/10.1016/S0079-6468(06)45501-6","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"45 ","pages":"1-61"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(06)45501-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26536790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Tuberculosis chemotherapy: recent developments and future perspectives. 结核病化疗:最近的发展和未来的展望。
Progress in medicinal chemistry Pub Date : 2007-01-01 DOI: 10.1016/S0079-6468(06)45504-1
Veemal Bhowruth, Lynn G Dover, Gurdyal S Besra
{"title":"Tuberculosis chemotherapy: recent developments and future perspectives.","authors":"Veemal Bhowruth, Lynn G Dover, Gurdyal S Besra","doi":"10.1016/S0079-6468(06)45504-1","DOIUrl":"https://doi.org/10.1016/S0079-6468(06)45504-1","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"45 ","pages":"169-203"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(06)45504-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26536793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
DPPIV inhibition: promising therapy for the treatment of type 2 diabetes. DPPIV抑制:治疗2型糖尿病的有希望的疗法。
Progress in medicinal chemistry Pub Date : 2007-01-01 DOI: 10.1016/S0079-6468(06)45502-8
Paul E Wiedeman
{"title":"DPPIV inhibition: promising therapy for the treatment of type 2 diabetes.","authors":"Paul E Wiedeman","doi":"10.1016/S0079-6468(06)45502-8","DOIUrl":"https://doi.org/10.1016/S0079-6468(06)45502-8","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"45 ","pages":"63-109"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(06)45502-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26536791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Recent progress toward nonpeptide ligands for the melanocortin-4 receptor. 黑素皮质素-4受体非肽配体研究进展。
Progress in medicinal chemistry Pub Date : 2007-01-01 DOI: 10.1016/S0079-6468(06)45503-X
Chen Chen
{"title":"Recent progress toward nonpeptide ligands for the melanocortin-4 receptor.","authors":"Chen Chen","doi":"10.1016/S0079-6468(06)45503-X","DOIUrl":"https://doi.org/10.1016/S0079-6468(06)45503-X","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"45 ","pages":"111-67"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6468(06)45503-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26536792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信